Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2021 Volume 21 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2021 Volume 21 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes

Corrigendum in: /10.3892/etm.2023.12040
  • Authors:
    • Xiangying Ma
    • Zhiheng Zhang
    • Meilun Shen
    • Yuanqiang Ma
    • Rouqian Li
    • Xiaodi Jin
    • Li Gao
    • Zhi Wang
  • View Affiliations / Copyright

    Affiliations: College of Veterinary Medicine, Northeast Agricultural University, Harbin, Heilongjiang 150030, P.R. China, College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia 010018, P.R. China
    Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 582
    |
    Published online on: April 2, 2021
       https://doi.org/10.3892/etm.2021.10014
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteoarthritis (OA) is characterized by progressive degeneration of cartilage, formation of cartilage at the cartilage edge, and remodeling of the subchondral bone. Pro‑inflammatory cytokines [e.g., interleukin (IL)‑1β] that induce inflammation and promote chondrocyte damage induce OA. Currently, the diagnosis of OA is commonly based on imaging examinations (e.g., X‑ray) and evaluations of clinical symptoms; however, biomarkers that can effectively diagnose OA are currently not available. By studying the mechanism underlying OA cartilage injury and changes in the concentrations of the biomarkers procollagen type II carboxy‑terminal propeptide (PIICP), collagen type‑II C‑telopeptide fragments (CTX‑II), and type II collagen cleavage neoepitope (C2C) during pathogenesis, the present study established a theoretical basis for the evaluation and early diagnosis of OA. In an experiment, 10 ng/ml IL‑1β was used to the treat chondrocyte‑induced OA models in vitro for 0, 12, 24 and 48 h. Western blotting was used to detect the expression levels of matrix metalloproteinase (MMP)‑3, MMP‑13, and inducible nitric oxide synthase (iNOS) protein at each time‑point. The concentrations of CTX‑II, C2C, and PIICP in the cell culture supernatant were detected by ELISA kit. A biochemical kit was used to detect changes of nitric oxide (NO) in the cell culture supernatant. In addition, chondrocytes were treated with 10 ng/ml IL‑1β for 0, 30, 60 and 90 min and the translocation and phosphorylation of the NF‑κB pathway were investigated by western blotting. Following IL‑1β stimulation, the NF‑κB pathway was activated to increase the expression levels of MMPs and iNOS synthesis downstream of the pathway, resulting in an increased degradation of type II collagen (Col II). To sum up, pro‑inflammatory IL‑1β induced an OA chondrocyte model. During the development of OA, the expression of MMPs and NO increased and Col II was degraded.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

French HP, Galvin R, Horgan F and Kenny RA: Prevalence and burden of osteoarthritis amongst older people in Ireland: Findings from The Irish LongituDinal study on ageing (TILDA). Osteoarthritis Cartilage. 23(A188)2015.PubMed/NCBI View Article : Google Scholar

2 

Abramson SB and Attur M: Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther. 11(227)2009.PubMed/NCBI View Article : Google Scholar

3 

Scanzello CR and Goldring SR: The role of synovitis in osteoarthritis pathogenesis. Bone. 51:249–257. 2012.PubMed/NCBI View Article : Google Scholar

4 

Momin M, Guoqing L, Yang W and Li C: Protective effects of gemigliptin against type II collagen degradation in human chondrocytes. Biomed Pharmacother. 104:590–954. 2018.PubMed/NCBI View Article : Google Scholar

5 

Haseeb A and Haqqi TM: Immunopathogenesis of osteoarthritis. Clin Immunol. 146:185–196. 2013.PubMed/NCBI View Article : Google Scholar

6 

Muto T, Kokubu T, Mifune Y, Inui A, Harada Y, Yoshifumi Takase F, Kuroda R and Kurosaka M: Temporary inductions of matrix metalloprotease-3 (MMP-3) expression and cell apoptosis are associated with tendon degeneration or rupture after corticosteroid injection. J Orthop Res. 32:1297–1304. 2014.PubMed/NCBI View Article : Google Scholar

7 

Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF and Hambor JE: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest. 97:761–768. 1996.PubMed/NCBI View Article : Google Scholar

8 

Ying X, Chen X, Cheng S, Shen Y, Peng L and Xu HZ: Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte. Int Immunopharmacol. 17:293–299. 2013.PubMed/NCBI View Article : Google Scholar

9 

Patra D and Sandell L: Evolving biomarkers in osteoarthritis. J Knee Surg. 24:241–249. 2011.PubMed/NCBI View Article : Google Scholar

10 

Sugiyama S, Itokazu M, Suzuki Y and Shimizu K: Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis. 62:27–32. 2003.PubMed/NCBI View Article : Google Scholar

11 

Dejica VM, Mort JS, Laverty S, Antoniou J, Zukor DJ, Tanzer M and Poole AR: Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage. Arthritis Res Ther. 14(R113)2012.PubMed/NCBI View Article : Google Scholar

12 

Boeth H, Macmahon A, Poole AR, Buttgereit F, Önnerfjord P, Lorenzo P, Klint C, Pramhed A and Duda GN: Differences in biomarkers of cartilage matrix turnover and their changes over 2 years in adolescent and adult volleyball athletes. J Exp Orthop. 4(7)2017.PubMed/NCBI View Article : Google Scholar

13 

Madzuki IN, Lau SF, Che Ahmad Tantowi NA, Mohd Ishak NI and Mohamed S: Labisia pumila prevented osteoarthritis cartilage degeneration by attenuating joint inflammation and collagen breakdown in postmenopausal rat model. Infammopharmacology. 26:1207–1217. 2018.PubMed/NCBI View Article : Google Scholar

14 

Li Y, Wang J, Song X, Bai H, Ma T, Zhang Z, Li X, Jiang R, Wang G, Fan X, et al: Effects of baicalein on IL-1β-induced inflammation and apoptosis in rat articular chondrocytes. Oncotarget 8:. 8:90781–90795. 2017.PubMed/NCBI View Article : Google Scholar

15 

Liu B, Zhou Y, Chen X and Peng D: IL-1β-mediated NF-κB signaling augments the osteosarcoma cell growth through modulating miR-376c/TGFA axis. Die Pharmazie. 72:419–424. 2017.PubMed/NCBI View Article : Google Scholar

16 

Wu H, Zhang M, Li W, Zhu S and Zhang D: Stachydrine attenuates IL-1β-induced inflammatory response in osteoarthritis chondrocytes through the NF-κB signaling pathway. Chem Biol Interact. 326(109136)2020.PubMed/NCBI View Article : Google Scholar

17 

Liacini A, Sylvester J, Li WQ and Zafarullah M: Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 21:251–162. 2002.PubMed/NCBI View Article : Google Scholar

18 

Zheng W, Chen C, Zhang C, Cai L and Chen H: The protective effect of phloretin in osteoarthritis: An in vitro and in vivo study. Food Funct. 9:263–278. 2018.PubMed/NCBI View Article : Google Scholar

19 

Perkins ND: The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132. 2012.PubMed/NCBI View Article : Google Scholar

20 

Mobasheri A, Bay-Jensen AC, van Spil WE, Larkin J and Levesque MC: Osteoarthritis year in review 2016: Biomarkers (biochemical markers). Osteoarthritis Cartilage. 25:199–208. 2017.PubMed/NCBI View Article : Google Scholar

21 

Zhang L, Ma S, Su H and Cheng J: Isoliquiritigenin inhibits IL-1β-induced production of matrix metalloproteinase in articular chondrocytes. Mol Ther Methods Clin Dev. 9:153–159. 2018.PubMed/NCBI View Article : Google Scholar

22 

Huang X, Pan Q, Mao Z, Zhang R, Ma X, Xi Y and You H: Sinapic acid inhibits the IL-1β-induced inflammation via MAPK downregulation in rat chondrocytes. Inflammation. 41:562–568. 2018.PubMed/NCBI View Article : Google Scholar

23 

Hayashi D, Roemer FW and Guermazi A: Imaging for osteoarthritis. Ann Phys Rehabil Med. 59:161–169. 2016.PubMed/NCBI View Article : Google Scholar

24 

Mobasheri A and Batt M: An update on the pathophysiology of osteoarthritis. Ann Phys Rehabil Med. 59:333–339. 2016.PubMed/NCBI View Article : Google Scholar

25 

Charlier E, Deroyer C, Ciregia F, Malaise O, Neuville S, Plener Z, Malaise M and de Seny D: Chondrocyte dedifferentiation and osteoarthritis (OA). Biochem Pharmacol. 165:49–65. 2019.PubMed/NCBI View Article : Google Scholar

26 

Li H, Wang D, Yuan Y and Min J: New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis. Arthritis Res Ther. 19(248)2017.PubMed/NCBI View Article : Google Scholar

27 

Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M and Poole AR: Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum. 46:2087–2094. 2002.PubMed/NCBI View Article : Google Scholar

28 

Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R and Poole AR: Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest. 96:2859–2869. 1995.PubMed/NCBI View Article : Google Scholar

29 

Mehana EE, Khafaga AF and El-Blehi SS: The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review. Life Sci. 234(116786)2019.PubMed/NCBI View Article : Google Scholar

30 

Xia B, Di Chen Zhang J, Hu S, Jin H and Tong P: Osteoarthritis pathogenesis: A review of molecular mechanisms. Calcif Tissue Int. 95:495–505. 2014.PubMed/NCBI View Article : Google Scholar

31 

Zhou K, Hu L, Liao W, Yin D and Rui F: Coptisine prevented IL-β-induced expression of inflammatory mediators in chondrocytes. Inflammation. 39:1558–1565. 2016.PubMed/NCBI View Article : Google Scholar

32 

Berenbaum F: Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 21:16–21. 2013.PubMed/NCBI View Article : Google Scholar

33 

de Visser HM, Sanchez C, Mastbergen SC, Lafeber FPJG, Henrotin YE and Weinans H: Fib3-3 as a biomarker for osteoarthritis in a rat model with metabolic dysregulation. Cartilage. 10:329–334. 2019.PubMed/NCBI View Article : Google Scholar

34 

Lee HJ, Lee SM, Moon YG, Jung YS, Lee JH, Venkatarame Gowda Saralamma V, Kim YS, Pak JE, Lee HJ, Kim GS and Heo JD: Membrane-free stem cell components inhibit interleukin-1α-stimulated inflammation and cartilage degradation in vitro and in vivo: A rat model of osteoarthritis. Int J Mol Sci. 20(4869)2019.PubMed/NCBI View Article : Google Scholar

35 

Vilá S: Inflammation in osteoarthritis. P R Health Sci J. 36:123–129. 2017.PubMed/NCBI

36 

Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, El Hachem K, Hashimoto K, Roach HI, Olivotto E, Borzì RM and Marcu KB: Roles of inflammatory and anabolic cytokines in cartilage metabolism: Signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater. 21:202–220. 2011.PubMed/NCBI View Article : Google Scholar

37 

Zeng JZ, Ma LF, Meng H, Yu HM, Zhang YK and Guo A: Effect of Ginkgo biloba extract on matrix metalloproteinase-3 expression in a rat model of chondrocyte injury. Genet Mol Res. 14:18280–18286. 2015.PubMed/NCBI View Article : Google Scholar

38 

Piecha D, Weik J, Kheil H, Becher G, Timmermann A, Jaworski A, Burger M and Hofmann MW: Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants. Inflamm Res. 59:379–389. 2010.PubMed/NCBI View Article : Google Scholar

39 

Rigoglou S and Papavassiliou AG: The NF-κB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 45:2580–2584. 2013.PubMed/NCBI View Article : Google Scholar

40 

Jimi E, Fei H and Nakatomi C: NF-κB signaling regulates physiological and pathological chondrogenesis. Int J Mol Sci. 20(6275)2019.PubMed/NCBI View Article : Google Scholar

41 

De Luca F: Role of nuclear factor kappa B (NF-κB) in growth plate chondrogenesis. Pediatr Endocrinol Rev. 13:720–730. 2016.PubMed/NCBI

42 

Robinson SM and Mann DA: Role of nuclear factor kappaB in liver health and disease. Clin Sci (Lond). 118:691–705. 2010.PubMed/NCBI View Article : Google Scholar

43 

Dai W, Liang Z, Liu H, Zhao G and Ju C: Lunasin abrogates the expression of matrix metalloproteinases and reduction of type II collagen. Artif Cells Nanomed Biotechnol. 47:3259–3264. 2019.PubMed/NCBI View Article : Google Scholar

44 

Moqbel SAA, He Y, Xu L, Ma C, Ran J, Xu K and Wu L: Rat chondrocyte inflammation and osteoarthritis are ameliorated by madecassoside. Oxid Med Cell Longev. 2020(7540197)2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ma X, Zhang Z, Shen M, Ma Y, Li R, Jin X, Gao L and Wang Z: Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040. Exp Ther Med 21: 582, 2021.
APA
Ma, X., Zhang, Z., Shen, M., Ma, Y., Li, R., Jin, X. ... Wang, Z. (2021). Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040. Experimental and Therapeutic Medicine, 21, 582. https://doi.org/10.3892/etm.2021.10014
MLA
Ma, X., Zhang, Z., Shen, M., Ma, Y., Li, R., Jin, X., Gao, L., Wang, Z."Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040". Experimental and Therapeutic Medicine 21.6 (2021): 582.
Chicago
Ma, X., Zhang, Z., Shen, M., Ma, Y., Li, R., Jin, X., Gao, L., Wang, Z."Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040". Experimental and Therapeutic Medicine 21, no. 6 (2021): 582. https://doi.org/10.3892/etm.2021.10014
Copy and paste a formatted citation
x
Spandidos Publications style
Ma X, Zhang Z, Shen M, Ma Y, Li R, Jin X, Gao L and Wang Z: Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040. Exp Ther Med 21: 582, 2021.
APA
Ma, X., Zhang, Z., Shen, M., Ma, Y., Li, R., Jin, X. ... Wang, Z. (2021). Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040. Experimental and Therapeutic Medicine, 21, 582. https://doi.org/10.3892/etm.2021.10014
MLA
Ma, X., Zhang, Z., Shen, M., Ma, Y., Li, R., Jin, X., Gao, L., Wang, Z."Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040". Experimental and Therapeutic Medicine 21.6 (2021): 582.
Chicago
Ma, X., Zhang, Z., Shen, M., Ma, Y., Li, R., Jin, X., Gao, L., Wang, Z."Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes Corrigendum in /10.3892/etm.2023.12040". Experimental and Therapeutic Medicine 21, no. 6 (2021): 582. https://doi.org/10.3892/etm.2021.10014
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team